-
Marcolina ST. Nonpharmacologic management of migraines. Altern Med Alert 2007;10(6):61-65.
-
The ECG Figure in the article was obtained from an older woman who was seen in the Emergency Department with a chief complaint of weakness of several days duration.
-
Patients at high risk for VTE should be treated with three times daily UH, while patients at lower risk may be treated with twice daily therapy.
-
For women, up to 20% of all coronary events occur in the absence of traditional major risk factors, and many women with these risk factors do not develop coronary events.
-
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years.
-
Persons who do not suffer hyperhidrosis (HID) may be surprised to learn that it has been associated with both occupational and physical impairment, as well as limitations in social interaction.
-
A new class of drug has been approved for the treatment of cutaneous T-cell lymphoma (CTCL) such as mycosis fungoides.
-
A simple questionnaire can identify individuals at risk for chronic kidney disease.
-
Botulinum Toxin for Treatment of Hyperhidrosis; A Fish Story; Diabetes Control: It's More Than Just A1c Control; MI: Try to have it Monday Thru Friday; Can MRI Provide Better Clarity About Contralateral Breast Cancer?; Dapsone Gel 5% for Acne
-
Gonococcal Infections, CDC's Updated Treatment; Head Lice Malathion First-Line Treatment; Statins, May Cut the Risk of Cataracts; FDA Actions